UBS inks €77m forward-funding deal for UK life sciences asset

UBS Asset Management (UBS-AM) Real Estate & Private Markets (REPM) has agreed to provide £66 mln (€77 mln) in forward funding for a pharmaceutical facility in Stevenage, UK, working with development partner Reef Estates.

Would you like to read more? Log in first (top right of the screen) or take a trial.


Latest news

Best read stories

  • img

    Life Science REIT makes first buy since IPO

    • 02-Dec-2021

    Life Science REIT, a real estate investment trust focused on UK life science properties, has completed the acquisition of Rolling Stock Yard, a nine-storey office and laboratory building near London's St Pancras station from a joint venture of Newmark Properties, Argo Real Estate and Investec Bank.

    Read more